U.S. stocks mostly rose on Tuesday after strong earnings from Equifax, Hasbro and other companies, while oil prices eased after nearing their highest level since the war with Iran began. Brent crude fell below $109 a barrel after nearing $112 in the morning. The S&P 500 gained 0.3% to 7,712.57, and the Dow rose 1% to 52,495.88, while the Nasdaq composite slipped less than 0.1% as drops in Apple and Meta Platforms weighed on big tech. The Russell 2000 rose 1.7%, and the S&P 500 is up 12.7% for the year.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
S&P 500Dow JonesNasdaqoil prices
Open a keyword to see other news on the same topic.
Related tickers and likely impact
QQQ
• NeutralInvesco QQQ Trust
Relevance: low
| Market | US stocks |
|---|---|
| Sector | ETF |
| Close on 10/20/2026 | 717.52 |
| Change that session | -0.12% |
SPY
• NeutralSPDR S&P 500 ETF
Relevance: low
| Market | US stocks |
|---|---|
| Sector | ETF |
| Close on 10/20/2026 | 769.01 |
| Change that session | +0.33% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Stock Market News for Oct 20, 2026
Wall Street ended mixed on Monday as oil market risks persisted amid geopolitical tensions, with the Nasdaq Composite and S&P 500 finishing higher and the Dow lower. The Dow Jones Industrial Average fell 0.1%, or 36.38 points, to close at 51,966.03, with 18 of its 30 components ending lower; JPMorgan Chase & Co. (JPM) was the biggest loser, down 1.8%. The Nasdaq Composite rose 1.1% to 26,430.89 and the S&P 500 gained 0.4% to 7,690.73, while the CBOE Volatility Index fell 7.75% to 18.44. Consumer Discretionary (XLY) rose 2.7%, Information Technology (XLK) gained 1.2%, and Real Estate (XLRE) fell 1.2%. Oil gained after attacks on Saudi energy infrastructure revived supply concerns, with Brent crude up 0.37% to $109.96 a barrel and WTI up 0.27% to $98.81.
- Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50 - Day Line
Nasdaq Composite rose 1.11% and S&P 500 gained 0.66% on Oct. 19, 2026, led by big tech in a late rebound, while the Dow slipped 0.07% and the Russell 2000 added 0.25%. The VIX fell 1.55 points to 18.44, though the Nasdaq-100 volatility gauge rose 4.24 points. WTI crude closed at $98.41 per barrel, down 2.96% on the day but up 71.39% year to date, gold ended at $4,157.80 per ounce, and the 10-year Treasury yield rose to 5.14%. The article also notes Lockheed Martin's C-130J-30 delivery to the U.S. Navy, F.N.B. Corporation's third-quarter 2026 net income of $152.9 million, and Haemonetics' FDA approval of its PerQseal Elite system.
- Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50 - Day Line
US stocks rebounded into the close on October 19, 2026, with the Nasdaq Composite up 1.11% and the S&P 500 up 0.66%, while the Dow Jones slipped 0.07%. The VIX fell 1.55 points to 18.44, the S&P 500 closed at 7,709.63 and the Nasdaq Composite at 26,430.89. In commodities, WTI crude closed at $98.41 per barrel, down 2.96% on the day, gold slipped 0.56% to $4,157.80 per ounce, and the 10-year Treasury yield rose to 5.14%. The report also covers company news: Lockheed Martin delivered a C-130J-30 to the U.S. Navy for conversion into the E-130J Phoenix II, F.N.B. Corporation reported third-quarter net income of $152.9 million ($0.43 per diluted share), and Haemonetics received FDA approval for its PerQseal Elite closure system.
- Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50 - Day Line
The Nasdaq Composite rose 1.11% and the S&P 500 gained 0.66% in the session, while the Dow slipped 0.07% and settled just under its 50-day EMA near 52,010. The VIX fell 1.55 points to 18.44, even as the Nasdaq-100 volatility gauge jumped 4.24 points. WTI crude closed at $98.41 per barrel, down 2.96% on the day, gold ended at $4,157.80 per ounce, and the 10-year Treasury yield rose 4 basis points to 5.14%. On the corporate side, Lockheed Martin delivered a C-130J-30 to the U.S. Navy on Oct. 15 for conversion into the E-130J Phoenix II, F.N.B. reported third-quarter 2026 net income of $152.9 million ($0.43 per diluted share) versus $149.5 million ($0.41) a year earlier, and Haemonetics received FDA approval for its PerQseal Elite vascular closure system.
- Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50 - Day Line
The Nasdaq Composite rose 1.11% to 26,430.89 and the S&P 500 gained 0.66% to 7,709.63 on October 19, as big tech drove a sharp rebound into the close. The Dow Jones slipped 0.07% to 51,966.03, settling just under its 50-day EMA near 52,010, while the VIX fell 1.55 points to 18.44. In commodities, WTI crude closed at $98.41 per barrel and gold slipped 0.56% to $4,157.80 per ounce. The article also covers corporate news: Lockheed Martin delivered a C-130J-30 to the U.S. Navy, F.N.B. Corporation reported third-quarter net income of $152.9 million, and Haemonetics received FDA approval for its PerQseal Elite system.
- Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50 - Day Line
The Nasdaq Composite rose 1.11% and the S&P 500 gained 0.66% in a session led by big tech, while the Dow Jones Industrial Average slipped 0.07% and settled just under its 50-day EMA near 52,010. The VIX fell 1.55 points to 18.44, even as the Nasdaq-100 volatility gauge jumped 4.24 points. The indexes closed at 7,709.63 for the S&P 500, 26,430.89 for the Nasdaq Composite, 51,966.03 for the Dow and 2,728.30 for the Russell 2000. WTI crude closed at $98.41 per barrel and gold at $4,157.80 per ounce, while the 10-year Treasury yield rose to 5.14%. The article also covers Lockheed Martin and F.N.B. Corporation, which reported third-quarter net income of $152.9 million, or $0.43 per diluted share.
Related markets
Latest news
- JPMorgan Puts a Number on Bitcoin for the First Time: 10% a Year, With a Big Caveat
J.P. Morgan Asset Management projected a 10% compound annual return for Bitcoin over the next 10 to 15 years in its 2027 Long-Term Capital Market Assumptions, the first time the report includes the asset. That forecast tops its estimates for U.S. large-cap stocks (7.5%), gold (5.5%) and a 60/40 stock-bond portfolio (7%), but the report puts Bitcoin's annualized volatility at 55%, versus about 17% for gold. The firm still excludes Bitcoin from its main covariance matrices, citing volatility and unstable correlations, and rejected the currency debasement bull case as “wide of the mark.” Bitwise's Matt Hougan welcomed the forecast but argued the 55% volatility assumption is too high, making the return estimate too conservative. Meanwhile, U.S. spot Bitcoin ETFs drew $526.7 million on Monday, trimming October's net outflows to about $88 million.
- JPMorgan Puts a Number on Bitcoin for the First Time: 10% a Year, With a Big Caveat
J.P. Morgan Asset Management projected a 10% compound annual return for Bitcoin over the next 10 to 15 years in its 2027 Long-Term Capital Market Assumptions, the first time the report includes the asset. That forecast tops its estimates for U.S. large-cap stocks (7.5%), gold (5.5%) and a 60/40 stock-bond portfolio (7%), but the report puts Bitcoin's annualized volatility at 55%, versus about 17% for gold. The firm still excludes Bitcoin from its main covariance matrices, citing volatility and unstable correlations, and rejected the currency debasement bull case as “wide of the mark.” Bitwise's Matt Hougan welcomed the forecast but argued the 55% volatility assumption is too high, making the return estimate too conservative. Meanwhile, U.S. spot Bitcoin ETFs drew $526.7 million on Monday, trimming October's net outflows to about $88 million.
- U.S. CFTC sets agenda for AI forum, exploring trading and agentic finance
The U.S. Commodity Futures Trading Commission released the agenda for its first “Frontier Forum” event, hosted by its Innovation Task Force on October 28, to discuss how AI may change U.S. derivatives markets. The session will look at how AI could affect price discovery and risk management, and will hear from leaders of firms including Ornn, Architect and Liquid Compute. Participants will also explore how traders’ own AI agents may operate under CFTC regulations. CFTC Chairman Mike Selig said super intelligence is poised to transform financial markets.
- Archer vs Joby: What's the Better eVTOL Stock to Buy Right Now?
The article compares Joby Aviation and Archer Aviation, two eVTOL (flying taxi) companies nearing FAA approval but still unprofitable. For the six months ended June 30, Archer had $1.6 billion in cash and short-term investments and used $305.5 million in operations, while Joby had $2.3 billion and used $317.6 million, so Joby may need a smaller cash infusion. Joby generated $38.6 million in revenue last quarter, helped by its Blade Air Mobility passenger business, but its net loss was $245 million versus Archer's $263 million. Joby's $4.7 billion market cap is well above Archer's $3.1 billion, and the author favors Archer on valuation. Both stocks remain highly volatile and face a long road before turning profitable.
- Stock Market Today, Oct. 20: Netflix Q3 Revenue Rises 12% on Pricing Power
Netflix closed at $68.66, down 1.70%, ahead of its after-close Q3 report, and was down 5.1% in after-hours trading as of 4:31 p.m. ET. Q3 revenue rose 12% year over year to $12.9 billion, and diluted EPS climbed from $0.59 to $0.87. Netflix outperformed every metric for which it provides quarterly guidance, with larger profit surprises than revenue surprises, but its fourth-quarter guidance looked muted, with slower sales growth and lower profit from seasonal effects and impairment costs tied to recently announced job cuts. That day, the S&P 500 closed at 7,711 (up 0.26%) and the Nasdaq Composite at 26,425 (down 0.02%).
- 2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)
The article examines Johnson & Johnson (JNJ) and Amgen (AMGN), two dividend stocks that have outperformed the market in 2026. For J&J, revenue and earnings beat expectations and guidance was slightly raised, but its medtech unit faces weaker Impella demand and a Class 1 recall in the U.S.; the article still sees long-term prospects intact, citing new drug launches, the OTTAVA surgical system, a proposed $5.5 billion talc settlement and a 64-year dividend increase streak. Amgen's second-quarter revenue rose 10% to $10.1 billion despite FDA moves to remove Tavneos and falling denosumab sales after losing exclusivity. The article says growth drivers such as Tezspire, Tepezza and the MariTide obesity candidate could offset these headwinds.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.